Sort
35,931 grants matching “parkinsons”
The Neural Bases of Placebo Effects and their Relation to Regulatory Processes
$644,555Tor Dessart Wager · University Of Colorado · R01 · FY2016 · MH
Dissecting the complex role of microglia states in glaucoma
$644,506Richard T Libby · University Of Rochester · R01 · FY2024 · EY
The Dynamic AMPA Receptor Interactome During Plasticity and Learning
$644,481Richard L Huganir · Johns Hopkins University · R37 · FY2022 · NS
Effects of Parkinson's Disease on Perception, Cognition, and Gait
$644,424Alice M. Cronin-Golomb · Boston University (Charles River Campus) · R01 · FY2011 · NS
Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy
$644,224Gulin Oz · University Of Minnesota · R01 · FY2022 · NS
Metabolic control of gut-brain axis in Familial Dysautonomia
$644,043Frances Lefcort · Montana State University - Bozeman · R01 · FY2020 · DK
Positive Allosteric Modulators as PET Imaging Ligans for mGluR4
$643,961Anna-Liisa Brownell · Massachusetts General Hospital · R01 · FY2016 · NS
The Gut Brain Parkinson's Disease Consortium (GBPDC): Coordinating and Data Management Center (CDMC)
$643,884Lisa M Wruck · Duke University · U24 · FY2024 · DK
Exploiting Dopamine Receptor Functional Selectivity as an Approach to Treat Parkinson's Symptoms
$643,836Marc G. Caron · Duke University · R01 · FY2018 · NS
Genetic Silencing of Striatal CaV1.3 Calcium Channels as a Potent Antidyskinetic Therapy for PD
$643,792Kathy Steece Steece-Collier · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2025 · NS
The neurobiology of two distinct subtypes of neurodegenerative apraxia of speech: phenotypes of Alzheimer disease related 4-repeat tauopathies
$643,385Keith A Josephs · Mayo Clinic Rochester · R01 · FY2025 · DC
An ODNP Probe to Study Hydration Dynamics in Membrane Protein
$643,226Thorsten Maly · Bridge 12 Technologies, Inc. · R44 · FY2019 · GM
Cytokinesis and the Septin Cytoskeleton
$643,078Erfei Bi · University Of Pennsylvania · R35 · FY2024 · GM
KIR and HLA effects in CNS paraneoplastic syndromes and related neuroimmune conditions
$642,896Emmanuel J Mignot · Stanford University · U01 · FY2022 · NS
LRRK2 and inflammasome pathway in Parkinson's disease
$642,851Wanli W Smith · Johns Hopkins University · R01 · FY2023 · NS
Benchtop Q-Band Pulsed EPR Spectrometer for Intermolecular Distance Measurements
$642,724Thorsten Maly · Bridge 12 Technologies, Inc. · R44 · FY2023 · GM
Neuroimmunotoxicology: autoimmunity, inflammation, age, environmental agents
$642,713Gaylia Jean Harry · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES
Links Between Production and Perception in Speech
$642,698Doug H Whalen · Haskins Laboratories, Inc. · R01 · FY2010 · DC
SPEECH MOVEMENT CLASSIFICATION FOR ASSESSING AND TREATING ALS
$642,629Jordan R Green · Mgh Institute Of Health Professions · R01 · FY2014 · DC
Core A: Administrative Core
$642,584Douglas R Galasko · University Of California, San Diego · P50 · FY2015 · AG
Protein Structure, Stability, and Amyloid Formation
$642,558Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
3D molecular phenotyping of intact brain tissue via high-throughput active immunohistochemistry
$642,500Adam C Hall · Lifecanvas Technologies, Inc. · R44 · FY2021 · MH
Age of Onset and Huntingtons Disease
$642,465Cynthia Therese McMurray · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2010 · NS
A Vascularized Micro-Organ platform for the study of Brain-BBB-Blood interaction
$642,429Christopher C. W. Hughes · University Of California-Irvine · R61 · FY2021 · HL
Examining the role of phosphatidylethanolamine and autophagic disruption in Lewy Body Dementias and Parkinson's disease
$642,408Stephan N. Witt · Louisiana State Univ Hsc Shreveport · R56 · FY2021 · NS